ABCAF yields 1876.17% · JNJ yields 2.14%● Live data
📍 ABCAF pulled ahead of the other in Year 1
Combined, ABCAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABCAF + JNJ for your $10,000?
Athabasca Minerals Inc. develops and supplies aggregates and industrial minerals in Canada. The company operates through four segments: AMI Aggregates, AMI Silica, AMI RockChain, and TerraShift. It holds interest in the Richardson Quarry project comprising three metallic and industrial mineral leases covering an area of 3,904 hectares located to the north of Fort McMurray region. The company also holds interests in the Montney In-Basin project situated in the vicinity of Dawson Creek, Alberta and Fort St. John, British Columbia; the Duvernay project located in Alberta; and Firebag silica sand deposit located north of Fort McMurray, Alberta. In addition, it constructs, operates, and manages the Coffey Lake Public Pit located in north of Fort McMurray, Alberta. Further, it operates RockChain, a digital platform to provide integrated supply and transportation solutions industrial and construction markets; and offers engineering and project services, as well as proprietary technology applications, such as TerraMaps. The company serves multi-national companies, governmental bodies, and small and private companies in infrastructure, construction, power generation, aggregates, forestry, and energy sectors. The company was incorporated in 2006 and is headquartered in Edmonton, Canada.
Full ABCAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.